Can we all be happier with a more streamlined prior authorization process? This NEHI white paper provides context and recommendations.
What we’re thinking about at NEHI: two-way communication between patient communities and health care payers when new, novel and very challenging therapies are approved by the FDA.
UPDATE September 28, 2021: In the interest of public health during the ongoing COVID-19 pandemic, NEHI has made the decision to postpone our Innovators in Health Awards until further notice.
NEHI convened corporate and community leaders from around the country to help define a roadmap to collaborations that advance equitable health care and health outcomes for Americans who suffer from longstanding disparities.
This NEHI white paper outlines principles of good communication between health care payers and patients regarding newly approved novel therapies in our health care system.Download the Report
NEHI has released a report that proposes five principles of communication for shaping exchanges of information among patient groups and U.S. health care payers to enhance and promote trust in payer decision-making on coverage of novel therapies.Keep Reading
NEHI has partnered with Eli Lilly & Company and Avalere Health to release a new report today on advancing health and health care equity in the United States.Keep Reading